Have the Democrats Risked Ruin by Increasing Vaccine Hesitancy in the Electorate?
The Precautionary Principle and the politics of vaccine development
Read more...The Precautionary Principle and the politics of vaccine development
Read more...The wonky, seemingly semantic debate over SARS-COV-2 transmission has a real-world impact on what sort of protective measures health care companies need to take to protect their patients and workers.
Read more...How the ubiquitous phrase “access to health care” erases financial and “administrative burdens,” a fact now only beginning to be recognized by health are professionals.
Read more...Europe reported nearly 100,000 new Covid-19 infections on Thursday—more than in the U.S., India, and Brazil, the world’s Covid-19 case leaders
Read more...Trump believes he protected people with pre-existing conditions and eliminated surprise billing via an executive order. He did not.
Read more...Hong Kong, Vietnam, Taiwan, and New Zealand have recorded low COVID-19 deaths. Why do we hear so little about the reeasons for their success?
Read more...An illustration that some and perhaps many Trump voters don’t fit mainstream media stereotypes.
Read more...ngresscritters go after drug price gouging. But what will it take to make it stop?
Read more...Top economists warn of the dangers of the propsed Google acquisition of Fitbit and look at possible remedies.
Read more...Debunking yet another defense of the US’ abject Covid-19 performance.
Read more...learing up some confusion on herd immunity, a key topic in Covid-19 policy debates.
Read more...Operation Warp Speed is a public/private partnership set up by the Trump administration, which is developing several vaccines for Covid-19 in parallel.
Read more...The danger in the HHS Protect project on Covid-19 isn’t data manipulation, but what the data will be used for (which almost nobody is talking about).
Read more...A small, secret panel of experts is tasked with reviewing crucial data on the safety and effectiveness of coronavirus vaccines that U.S. taxpayers have helped fund, including products from Moderna, AstraZeneca, Johnson & Johnson and others.
Read more...New York state governor Andrew Cuomo steps into the debate over approval of covid-19 vaccine and will appoint panel to set NY distribution.
Read more...